Label: AFTERA- levonorgestrel tablet

  • NDC Code(s): 69536-103-88
  • Packager: Foundation Consumer Healthcare LLC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: New Drug Application Authorized Generic

Drug Label Information

Updated January 31, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • Active ingredient

    Levonorgestrel 1.5 mg

  • Purpose

    Emergency contraceptive

  • Use

    for women to reduce chance of pregnancy after unprotected sex (if a contraceptive failed or if you did not use birth control)

  • Warnings

    Allergy alert

    Do not use if you have ever had an allergic reaction to levonorgestrel

    Sexually transmitted diseases (STDs) alert

    This product does not protect against HIV/AIDS or other STDs

    Do not use

    • if you are already pregnant (because it will not work)
    • for regular birth control

    Ask a doctor or pharmacist before use if you are taking efavirenz (HIV medication) or rifampin (tuberculosis treatment) or medication for seizures (epilepsy). These medications may reduce the effectiveness of levonorgestrel.

    When using this product you may have

    • menstrual changes
    • tiredness
    • breast pain
    • nausea
    • headache
    • vomiting
    • lower stomach (abdominal) pain
    • dizziness

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control center right away.

  • Directions

    • take as soon as possible within 72 hours (3 days) after unprotected sex. The sooner you take it the better it will work.
    • if you vomit within 2 hours after taking the medication, call a healthcare professional to find out if you should repeat the dose
  • Other information

    • read the instructions, warnings and enclosed product leaflet before use
    • do not use if carton is open or tear strip is removed or blister seal is broken or missing
    • store at 20-25°C (68-77°F)
  • Inactive ingredients

    colloidal silicon dioxide, corn starch, lactose monohydrate, magnesium stearate, potato starch, talc

  • Questions?

    Call 1-888-919-0780

  • SPL UNCLASSIFIED SECTION

    Manufactured by:
    Gedeon Richter, Ltd., Budapest, Hungary

  • PRINCIPAL DISPLAY PANEL - 1.5 mg Tablet Blister Pack Box

    This item is
    electronically
    protected

    NDC 69536-103-88

    Emergency Contraceptive
    COMPARE TO PLAN B ONE-STEP®

    Aftera®
    LEVONORGESTREL 1.5 mg

    Reduces chance of pregnancy
    after unprotected sex.

    One Tablet.
    One Dose.

    NOT FOR REGULAR BIRTH CONTROL

    1 Tablet
    Levonorgestrel
    1.5 mg

    PRINCIPAL DISPLAY PANEL - 1.5 mg Tablet Blister Pack Box
  • INGREDIENTS AND APPEARANCE
    AFTERA 
    levonorgestrel tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69536-103
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LEVONORGESTREL (UNII: 5W7SIA7YZW) (LEVONORGESTREL - UNII:5W7SIA7YZW) LEVONORGESTREL1.5 mg
    Inactive Ingredients
    Ingredient NameStrength
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    STARCH, POTATO (UNII: 8I089SAH3T)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    TALC (UNII: 7SEV7J4R1U)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    Product Characteristics
    ColorWHITEScoreno score
    ShapeROUNDSize8mm
    FlavorImprint Code G00
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:69536-103-881 in 1 BOX, UNIT-DOSE05/10/2018
    11 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    NDA AUTHORIZED GENERICNDA02199805/10/2018
    Labeler - Foundation Consumer Healthcare LLC (079675882)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!